PICK A TIME SLOT
₹ Price not available
Jaipur
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Ankit Malhotra completed his MD in pathology in 2016 which was followed by a 3-year specialized hemato-oncology residency training in IRCH, AIIMS, New Delhi (2016-19). In this setup, his training involved morphological assessment of bone marrow specimens, advanced flow cytometry, fine needle aspiration cytology, and molecular diagnostics. Later, he also pursued a fellowship (2019-20) in Neuropathology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore where he acquired diagnostic skills in CNS/PNS tumors, immunohistochemistry, muscle biopsy, nerve biopsy, and learning how to set up a specialized neuropathology laboratory.
His research interest includes the diagnostics of both hematological and neurological cancers and has peer-reviewed publications in national and international journals. Currently, he is working as a consultant in Manipal hospital, Jaipur, and helping set up an advanced Hematopathology, Neuropathology, immunology & molecular diagnostics laboratory.
Dr. Malhotra is proficient in handling specialized hematopathology services including morphology, diagnostic flow cytometry, and minimal residual disease analysis in leukemia, lymphoma, and myelomas. In a similar vein, he also provides expertise in handling neuropathological specimens for all pathologies of the brain, spine, muscle, and nerve. He loves to teach and is active in various professional forums in his field.
His department also plans to introduce training workshops and seminars for students in his fields. He plans to acquire newer skills, especially in the fields of molecular pathology including next-generation sequencing and cellular therapies.
- Bone marrow aspiration and biopsy reporting
- Flow cytometric diagnosis of hematological malignancies
- Minimal residual disease analysis in leukemias, lymphomas, and myeloma
- Diagnosis of hemoglobinopathies and HPLC analysis
- Diagnosis of immunodeficiency disorders and immune function monitoring
- Quality control of hematology and flow cytometry laboratories
- Molecular diagnosis in hemato-lymphoid malignancies
- Bleeding and coagulation disorders
- Pathology of malignant and non-malignant brain & spinal cord disorders
- Intra-operative squash cytology for lesions of CNS/PNS
- Immunohistochemistry in neuro-oncology
- Nerve biopsy assessment
- Muscle biopsy assessment
- Surgical epilepsy pathology
- Forensic pathology
- Electron microscopic assessment
- Post-doctoral fellowship in Neuropathology, NIMHANS, Bangalore, 2020.
- English
- Hindi
- Punjabi
- Kannada
- Malhotra A, Rao S, Santhoshkumar R, Muralidharan N, Mitra S, Shetty S. Pigmented Ependymoma of the Fourth Ventricle—A Curious Entity: Report of a Rare Case With Review of Literature. International Journal of Surgical Pathology. 2020 May 25.
- Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A. A real world-perspective of CD123 expression in acute leukemia as a promising biomarker to predict treatment outcome in B-ALL and AML. Clinical Lymphoma Myeloma and Leukemia. 2020 May 11.
- Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian Journal of Pathology and Microbiology. 2019 Oct 1;62(4):614.
- Das N, Malhotra A, Gupta R, Rai S, Singh S, Sahoo RK, Gogia A, Bakshi S, Kumar L. Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S235.
- Das N, Malhotra A, Gupta R, Rai S, Gupta SK, Sahoo RK, Gogia A, Bakshi S, Kumar L, Singh S. CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S197.
- Malhotra A. Glioblastoma mimicking an abscess: a radio-pathological case report. Int. J. Med. Lab. Res. 2020; 5,2:69-72.
- Malhotra A, Suguna BV, Ravindra S. Unique spheroid deposits of amyloid in an ampullary neuroendocrine tumor. Indian Journal of Pathology and Microbiology. 2020 Aug.
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Talks & Publications
- Post-doctoral fellowship in Neuropathology, NIMHANS, Bangalore, 2020.
Dr. Ankit Malhotra completed his MD in pathology in 2016 which was followed by a 3-year specialized hemato-oncology residency training in IRCH, AIIMS, New Delhi (2016-19). In this setup, his training involved morphological assessment of bone marrow specimens, advanced flow cytometry, fine needle aspiration cytology, and molecular diagnostics. Later, he also pursued a fellowship (2019-20) in Neuropathology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore where he acquired diagnostic skills in CNS/PNS tumors, immunohistochemistry, muscle biopsy, nerve biopsy, and learning how to set up a specialized neuropathology laboratory.
His research interest includes the diagnostics of both hematological and neurological cancers and has peer-reviewed publications in national and international journals. Currently, he is working as a consultant in Manipal hospital, Jaipur, and helping set up an advanced Hematopathology, Neuropathology, immunology & molecular diagnostics laboratory.
Dr. Malhotra is proficient in handling specialized hematopathology services including morphology, diagnostic flow cytometry, and minimal residual disease analysis in leukemia, lymphoma, and myelomas. In a similar vein, he also provides expertise in handling neuropathological specimens for all pathologies of the brain, spine, muscle, and nerve. He loves to teach and is active in various professional forums in his field.
His department also plans to introduce training workshops and seminars for students in his fields. He plans to acquire newer skills, especially in the fields of molecular pathology including next-generation sequencing and cellular therapies.
- Bone marrow aspiration and biopsy reporting
- Flow cytometric diagnosis of hematological malignancies
- Minimal residual disease analysis in leukemias, lymphomas, and myeloma
- Diagnosis of hemoglobinopathies and HPLC analysis
- Diagnosis of immunodeficiency disorders and immune function monitoring
- Quality control of hematology and flow cytometry laboratories
- Molecular diagnosis in hemato-lymphoid malignancies
- Bleeding and coagulation disorders
- Pathology of malignant and non-malignant brain & spinal cord disorders
- Intra-operative squash cytology for lesions of CNS/PNS
- Immunohistochemistry in neuro-oncology
- Nerve biopsy assessment
- Muscle biopsy assessment
- Surgical epilepsy pathology
- Forensic pathology
- Electron microscopic assessment
- English
- Hindi
- Punjabi
- Kannada
- Malhotra A, Rao S, Santhoshkumar R, Muralidharan N, Mitra S, Shetty S. Pigmented Ependymoma of the Fourth Ventricle—A Curious Entity: Report of a Rare Case With Review of Literature. International Journal of Surgical Pathology. 2020 May 25.
- Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A. A real world-perspective of CD123 expression in acute leukemia as a promising biomarker to predict treatment outcome in B-ALL and AML. Clinical Lymphoma Myeloma and Leukemia. 2020 May 11.
- Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian Journal of Pathology and Microbiology. 2019 Oct 1;62(4):614.
- Das N, Malhotra A, Gupta R, Rai S, Singh S, Sahoo RK, Gogia A, Bakshi S, Kumar L. Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S235.
- Das N, Malhotra A, Gupta R, Rai S, Gupta SK, Sahoo RK, Gogia A, Bakshi S, Kumar L, Singh S. CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S197.
- Malhotra A. Glioblastoma mimicking an abscess: a radio-pathological case report. Int. J. Med. Lab. Res. 2020; 5,2:69-72.
- Malhotra A, Suguna BV, Ravindra S. Unique spheroid deposits of amyloid in an ampullary neuroendocrine tumor. Indian Journal of Pathology and Microbiology. 2020 Aug.
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Talks & Publications
- English
- Hindi
- Punjabi
- Kannada
Dr. Ankit Malhotra completed his MD in pathology in 2016 which was followed by a 3-year specialized hemato-oncology residency training in IRCH, AIIMS, New Delhi (2016-19). In this setup, his training involved morphological assessment of bone marrow specimens, advanced flow cytometry, fine needle aspiration cytology, and molecular diagnostics. Later, he also pursued a fellowship (2019-20) in Neuropathology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore where he acquired diagnostic skills in CNS/PNS tumors, immunohistochemistry, muscle biopsy, nerve biopsy, and learning how to set up a specialized neuropathology laboratory.
His research interest includes the diagnostics of both hematological and neurological cancers and has peer-reviewed publications in national and international journals. Currently, he is working as a consultant in Manipal hospital, Jaipur, and helping set up an advanced Hematopathology, Neuropathology, immunology & molecular diagnostics laboratory.
Dr. Malhotra is proficient in handling specialized hematopathology services including morphology, diagnostic flow cytometry, and minimal residual disease analysis in leukemia, lymphoma, and myelomas. In a similar vein, he also provides expertise in handling neuropathological specimens for all pathologies of the brain, spine, muscle, and nerve. He loves to teach and is active in various professional forums in his field.
His department also plans to introduce training workshops and seminars for students in his fields. He plans to acquire newer skills, especially in the fields of molecular pathology including next-generation sequencing and cellular therapies.
- Post-doctoral fellowship in Neuropathology, NIMHANS, Bangalore, 2020.
- Bone marrow aspiration and biopsy reporting
- Flow cytometric diagnosis of hematological malignancies
- Minimal residual disease analysis in leukemias, lymphomas, and myeloma
- Diagnosis of hemoglobinopathies and HPLC analysis
- Diagnosis of immunodeficiency disorders and immune function monitoring
- Quality control of hematology and flow cytometry laboratories
- Molecular diagnosis in hemato-lymphoid malignancies
- Bleeding and coagulation disorders
- Pathology of malignant and non-malignant brain & spinal cord disorders
- Intra-operative squash cytology for lesions of CNS/PNS
- Immunohistochemistry in neuro-oncology
- Nerve biopsy assessment
- Muscle biopsy assessment
- Surgical epilepsy pathology
- Forensic pathology
- Electron microscopic assessment
- Malhotra A, Rao S, Santhoshkumar R, Muralidharan N, Mitra S, Shetty S. Pigmented Ependymoma of the Fourth Ventricle—A Curious Entity: Report of a Rare Case With Review of Literature. International Journal of Surgical Pathology. 2020 May 25.
- Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A. A real world-perspective of CD123 expression in acute leukemia as a promising biomarker to predict treatment outcome in B-ALL and AML. Clinical Lymphoma Myeloma and Leukemia. 2020 May 11.
- Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian Journal of Pathology and Microbiology. 2019 Oct 1;62(4):614.
- Das N, Malhotra A, Gupta R, Rai S, Singh S, Sahoo RK, Gogia A, Bakshi S, Kumar L. Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S235.
- Das N, Malhotra A, Gupta R, Rai S, Gupta SK, Sahoo RK, Gogia A, Bakshi S, Kumar L, Singh S. CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S197.
- Malhotra A. Glioblastoma mimicking an abscess: a radio-pathological case report. Int. J. Med. Lab. Res. 2020; 5,2:69-72.
- Malhotra A, Suguna BV, Ravindra S. Unique spheroid deposits of amyloid in an ampullary neuroendocrine tumor. Indian Journal of Pathology and Microbiology. 2020 Aug.
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Talks & Publications
- Bone marrow aspiration and biopsy reporting
- Flow cytometric diagnosis of hematological malignancies
- Minimal residual disease analysis in leukemias, lymphomas, and myeloma
- Diagnosis of hemoglobinopathies and HPLC analysis
- Diagnosis of immunodeficiency disorders and immune function monitoring
- Quality control of hematology and flow cytometry laboratories
- Molecular diagnosis in hemato-lymphoid malignancies
- Bleeding and coagulation disorders
- Pathology of malignant and non-malignant brain & spinal cord disorders
- Intra-operative squash cytology for lesions of CNS/PNS
- Immunohistochemistry in neuro-oncology
- Nerve biopsy assessment
- Muscle biopsy assessment
- Surgical epilepsy pathology
- Forensic pathology
- Electron microscopic assessment
- Post-doctoral fellowship in Neuropathology, NIMHANS, Bangalore, 2020.
- English
- Hindi
- Punjabi
- Kannada
- Malhotra A, Rao S, Santhoshkumar R, Muralidharan N, Mitra S, Shetty S. Pigmented Ependymoma of the Fourth Ventricle—A Curious Entity: Report of a Rare Case With Review of Literature. International Journal of Surgical Pathology. 2020 May 25.
- Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A. A real world-perspective of CD123 expression in acute leukemia as a promising biomarker to predict treatment outcome in B-ALL and AML. Clinical Lymphoma Myeloma and Leukemia. 2020 May 11.
- Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian Journal of Pathology and Microbiology. 2019 Oct 1;62(4):614.
- Das N, Malhotra A, Gupta R, Rai S, Singh S, Sahoo RK, Gogia A, Bakshi S, Kumar L. Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S235.
- Das N, Malhotra A, Gupta R, Rai S, Gupta SK, Sahoo RK, Gogia A, Bakshi S, Kumar L, Singh S. CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S197.
- Malhotra A. Glioblastoma mimicking an abscess: a radio-pathological case report. Int. J. Med. Lab. Res. 2020; 5,2:69-72.
- Malhotra A, Suguna BV, Ravindra S. Unique spheroid deposits of amyloid in an ampullary neuroendocrine tumor. Indian Journal of Pathology and Microbiology. 2020 Aug.
Dr. Ankit Malhotra completed his MD in pathology in 2016 which was followed by a 3-year specialized hemato-oncology residency training in IRCH, AIIMS, New Delhi (2016-19). In this setup, his training involved morphological assessment of bone marrow specimens, advanced flow cytometry, fine needle aspiration cytology, and molecular diagnostics. Later, he also pursued a fellowship (2019-20) in Neuropathology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore where he acquired diagnostic skills in CNS/PNS tumors, immunohistochemistry, muscle biopsy, nerve biopsy, and learning how to set up a specialized neuropathology laboratory.
His research interest includes the diagnostics of both hematological and neurological cancers and has peer-reviewed publications in national and international journals. Currently, he is working as a consultant in Manipal hospital, Jaipur, and helping set up an advanced Hematopathology, Neuropathology, immunology & molecular diagnostics laboratory.
Dr. Malhotra is proficient in handling specialized hematopathology services including morphology, diagnostic flow cytometry, and minimal residual disease analysis in leukemia, lymphoma, and myelomas. In a similar vein, he also provides expertise in handling neuropathological specimens for all pathologies of the brain, spine, muscle, and nerve. He loves to teach and is active in various professional forums in his field.
His department also plans to introduce training workshops and seminars for students in his fields. He plans to acquire newer skills, especially in the fields of molecular pathology including next-generation sequencing and cellular therapies.
Field of Expertise
Fellowship & Membership
Languages Spoken
Talks & Publications
Overview
- Malhotra A, Rao S, Santhoshkumar R, Muralidharan N, Mitra S, Shetty S. Pigmented Ependymoma of the Fourth Ventricle—A Curious Entity: Report of a Rare Case With Review of Literature. International Journal of Surgical Pathology. 2020 May 25.
- Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A. A real world-perspective of CD123 expression in acute leukemia as a promising biomarker to predict treatment outcome in B-ALL and AML. Clinical Lymphoma Myeloma and Leukemia. 2020 May 11.
- Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A, Gupta R. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor. Indian Journal of Pathology and Microbiology. 2019 Oct 1;62(4):614.
- Das N, Malhotra A, Gupta R, Rai S, Singh S, Sahoo RK, Gogia A, Bakshi S, Kumar L. Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S235.
- Das N, Malhotra A, Gupta R, Rai S, Gupta SK, Sahoo RK, Gogia A, Bakshi S, Kumar L, Singh S. CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma, and Leukemia. 2019 Sep 1;19:S197.
- Malhotra A. Glioblastoma mimicking an abscess: a radio-pathological case report. Int. J. Med. Lab. Res. 2020; 5,2:69-72.
- Malhotra A, Suguna BV, Ravindra S. Unique spheroid deposits of amyloid in an ampullary neuroendocrine tumor. Indian Journal of Pathology and Microbiology. 2020 Aug.
Dr. Ankit Malhotra completed his MD in pathology in 2016 which was followed by a 3-year specialized hemato-oncology residency training in IRCH, AIIMS, New Delhi (2016-19). In this setup, his training involved morphological assessment of bone marrow specimens, advanced flow cytometry, fine needle aspiration cytology, and molecular diagnostics. Later, he also pursued a fellowship (2019-20) in Neuropathology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore where he acquired diagnostic skills in CNS/PNS tumors, immunohistochemistry, muscle biopsy, nerve biopsy, and learning how to set up a specialized neuropathology laboratory.
His research interest includes the diagnostics of both hematological and neurological cancers and has peer-reviewed publications in national and international journals. Currently, he is working as a consultant in Manipal hospital, Jaipur, and helping set up an advanced Hematopathology, Neuropathology, immunology & molecular diagnostics laboratory.
Dr. Malhotra is proficient in handling specialized hematopathology services including morphology, diagnostic flow cytometry, and minimal residual disease analysis in leukemia, lymphoma, and myelomas. In a similar vein, he also provides expertise in handling neuropathological specimens for all pathologies of the brain, spine, muscle, and nerve. He loves to teach and is active in various professional forums in his field.
His department also plans to introduce training workshops and seminars for students in his fields. He plans to acquire newer skills, especially in the fields of molecular pathology including next-generation sequencing and cellular therapies.
- Post-doctoral fellowship in Neuropathology, NIMHANS, Bangalore, 2020.
- Bone marrow aspiration and biopsy reporting
- Flow cytometric diagnosis of hematological malignancies
- Minimal residual disease analysis in leukemias, lymphomas, and myeloma
- Diagnosis of hemoglobinopathies and HPLC analysis
- Diagnosis of immunodeficiency disorders and immune function monitoring
- Quality control of hematology and flow cytometry laboratories
- Molecular diagnosis in hemato-lymphoid malignancies
- Bleeding and coagulation disorders
- Pathology of malignant and non-malignant brain & spinal cord disorders
- Intra-operative squash cytology for lesions of CNS/PNS
- Immunohistochemistry in neuro-oncology
- Nerve biopsy assessment
- Muscle biopsy assessment
- Surgical epilepsy pathology
- Forensic pathology
- Electron microscopic assessment
- English
- Hindi
- Punjabi
- Kannada
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
